Psilocybin clears biggest test yet, improving depression in phase 2b, but Compass stock falls amid chat about adverse events, durability - FierceBiotech

Submitted by Anonymous (not verified) on Wed, 11/10/2021 - 12:30

Psilocybin clears biggest test yet, improving depression in phase 2b, but Compass stock falls amid chat about adverse events, durability  FierceBiotech